<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=314834185700910&amp;ev=PageView&amp;noscript=1">

New Update: Healthcare Costs Increasing by Over 60% in Some States. Will you be impacted?

Learn More

Catalent Employees: How to Use Options Collars to Manage Appreciated Stock Without Triggering Taxes

image-table

Healthcare Provider Update: Healthcare Provider for Catalent Catalent, a prominent player in the biopharmaceutical industry, collaborates with various healthcare providers to optimize its services. One of the notable healthcare partners for Catalent is UnitedHealthcare, which often works with organizations like Catalent to ensure streamlined processes in drug delivery and related healthcare services. Potential Healthcare Cost Increases in 2026 In 2026, healthcare costs are expected to rise significantly, primarily driven by looming federal policies and medical inflation. Reports indicate that Affordable Care Act (ACA) premiums may surge due to the potential expiration of enhanced premium subsidies, causing many policyholders to face out-of-pocket increases of over 75%. Insurers are already proposing steep rate hikes, with some states expected to see increases as high as 66%. This combination of factors, including rising healthcare service costs and more aggressive premium strategies from insurers, is set to intensify financial pressures on consumers in the coming year. Click here to learn more

'Catalent employees navigating concentrated stock positions should view strategies like collars as part of a broader wealth and tax planning discussion that requires careful coordination with qualified professionals.' – Paul Bergeron, a representative of The Retirement Group, a division of Wealth Enhancement.

'Catalent employees with significant stock holdings can benefit from understanding how thoughtful planning techniques provide both flexibility and time to make informed decisions about future diversification.' – Tyson Mavar, a representative of The Retirement Group, a division of Wealth Enhancement.

In this article, we will discuss:

  1. How an options collar can help manage concentrated stock positions without triggering immediate taxes.

  2. Key considerations for constructive sale treatment under Section 1259.

  3. Practical examples and alternatives for Catalent employees holding appreciated stock.

By Tyson Mavar, advisor at Wealth Enhancement

The Difficulty of Keeping Valuable Stock

Many Catalent employees hold highly valued company stock, which may have been built up over years of employment or from investments that performed better than expected. Leaving these shares without a hedge exposes them to downside risk if the stock price falls, but selling would create a significant capital gains tax liability.

One method of limiting potential losses without selling outright is an options collar. Even if the stock is not sold, certain hedging techniques can be treated as taxable sales under Section 1259 of the Internal Revenue Code, which governs 'constructive sales.'

The Operation of an Options Collar

A collar strategy combines shares already owned with two option positions:

  • Put option:  Purchasing a put option gives you the right to sell shares at a set strike price. For example, if you own stock at $100 and buy a $90 put, you can still sell at $90 even if the price falls further.

  • Covered call:  Selling a call requires selling at a higher strike price. For instance, selling a $120 call limits gains above $120.

When paired, the call premium can offset the put’s cost. This creates a range where downside is limited and upside is capped. Additionally, with careful planning, the collar can often be cost-neutral.

The Use of Collars by Investors

Catalent stockholders and others might use collars in the following cases:

  • Concentrated positions:  A large portion of wealth tied to one company.

  • Market uncertainty:  When downside management is needed but selling isn’t desirable.

  • Estate and legacy planning:  Preserving value while postponing capital gains.

The Problem of Constructive Sales

Section 1259 defines some hedges as constructive sales, including:

  • - Short sales of stock you already own.

  • - Contracts for future delivery of the stock.

  • - Deep in-the-money calls and puts that eliminate both risk and reward.

If the IRS views a collar as removing nearly all economic exposure, it can be treated as a constructive sale, triggering immediate recognition of capital gains.

Collar Design to Steer Clear of Constructive Sales

To reduce the risk of Section 1259 issues, Catalent employees can structure collars with careful attention:

  • - Keep strike prices wide enough to allow both risk and reward.

  • - Use out-of-the-money calls and puts rather than in-the-money options.

  • - Roll collars forward instead of holding outdated positions.

  • - Document investment intent with an advisor.

An Example 

Suppose you hold $2 million in stock purchased years ago for $200,000. Selling outright could result in over $400,000 in federal taxes, depending on your state.

Instead, you might sell calls at 120% of the stock’s value and purchase puts at 80%. In this design:

  • - Losses are limited to 20%.

  • - Gains are capped above 120%.

  • - The position retains risk and reward, so it generally avoids being classified as a constructive sale.

This approach can provide time to manage sales across multiple tax years or to wait for a more favorable tax environment.

Considerations

Catalent employees considering collars should note:

  • Liquidity:  Large-cap companies usually have strong options markets.

  • Rolling:  Positions can be extended as expiration approaches.

  • Alternatives:  Other hedging tools include donor-advised funds, charitable remainder trusts, gifting strategies, or exchange funds.

  • Advisory guidance:  Given the complexity of constructive sale rules, consulting tax and legal professionals is critical.

The Bottom Line

Options collars can help Catalent employees preserve the value of appreciated stock while limiting downside and postponing taxable events. This strategy allows time for thoughtful diversification while maintaining both risk and opportunity. However, collars must be carefully designed to reduce the chance of triggering constructive sale treatment under the Internal Revenue Code.

Disclaimer:  This material is for educational purposes only. Alternative investments may not be suitable for all investors and involve special risks such as leveraging the investment, potential adverse market forces, regulatory changes, and potential illiquidity. Investing involves risk, including possible loss of principal. Always consult your tax professional before making decisions, as tax laws are complex and subject to change. 

Featured Video

Articles you may find interesting:

Loading...

Sources:

1. United States Congress.   26 U.S. Code §1259 - Constructive Sales Treatment for Appreciated Financial Positions.  Cornell Law School, Legal Information Institute, 5 Aug. 1997, amended 4 Oct. 2004.  https://www.law.cornell.edu/uscode/text/26/1259.

2. Internal Revenue Service.   Revenue Ruling 2003-7, 2003-1 C.B. 363.  2003.  https://www.irs.gov/pub/irs-drop/rr-03-7.pdf.

3. Options Industry Council (OIC).   Options Strategies Quick Guide.  The Options Clearing Corporation, 2021.  https://www.optionseducation.org/getattachment/007fe864-029a-490d-8dc1-3b58bd558f64/options-strategies-quick-guide.pdf?lang=en-US  

4. Internal Revenue Service.   2024 Instructions for Form 5227, Split-Interest Trust Information Return.  26 Nov. 2024.  https://www.irs.gov/pub/irs-pdf/i5227.pdf

What is the Catalent 401(k) Savings Plan?

The Catalent 401(k) Savings Plan is a retirement savings plan that allows employees to save for their future by contributing a portion of their salary on a pre-tax or Roth after-tax basis.

How can I enroll in the Catalent 401(k) Savings Plan?

Employees can enroll in the Catalent 401(k) Savings Plan by accessing the benefits portal or contacting Human Resources for guidance on the enrollment process.

What are the eligibility requirements for the Catalent 401(k) Savings Plan?

To be eligible for the Catalent 401(k) Savings Plan, employees typically need to be at least 21 years old and have completed a specified period of service with the company.

Does Catalent offer a company match for the 401(k) Savings Plan?

Yes, Catalent offers a company match for contributions made to the 401(k) Savings Plan, which helps employees maximize their retirement savings.

How much can I contribute to the Catalent 401(k) Savings Plan?

Employees can contribute up to the IRS annual limit to the Catalent 401(k) Savings Plan, which may vary each year. It’s important to check the current limits.

When can I start making contributions to the Catalent 401(k) Savings Plan?

Employees can start making contributions to the Catalent 401(k) Savings Plan after they complete the eligibility requirements and enroll in the plan.

Can I change my contribution amount in the Catalent 401(k) Savings Plan?

Yes, employees can change their contribution amount at any time during the year by accessing the benefits portal or contacting Human Resources.

What investment options are available in the Catalent 401(k) Savings Plan?

The Catalent 401(k) Savings Plan offers a variety of investment options, including mutual funds and target-date funds, allowing employees to choose based on their risk tolerance and retirement goals.

How often can I change my investment allocations in the Catalent 401(k) Savings Plan?

Employees can change their investment allocations in the Catalent 401(k) Savings Plan at any time, subject to the plan's trading restrictions.

What happens to my Catalent 401(k) Savings Plan if I leave the company?

If you leave Catalent, you have several options for your 401(k) Savings Plan, including rolling it over to another qualified plan, cashing it out, or leaving it in the Catalent plan if permitted.

With the current political climate we are in it is important to keep up with current news and remain knowledgeable about your benefits.
Catalent's Pension Plan: Catalent offers a comprehensive retirement benefits package designed to support its employees' financial wellness. The primary pension plan provided by Catalent is known as the "Catalent Pension Plan." This plan includes a defined benefit formula based on an employee’s years of service and final average pay. Typically, to qualify for the pension plan, employees must have a minimum of five years of service and be at least 55 years of age. The specific pension formula details and eligibility criteria are laid out in the employee benefits documentation provided internally by Catalent​ (Catalent)​ (Catalent Investor Relations)​ (FiercePharma). Catalent's 401(k) Plan: Catalent also offers a 401(k) plan to its employees, which is referred to as the "Catalent 401(k) Savings Plan." Employees are eligible to participate in the 401(k) plan from their first day of employment. The company provides a generous matching contribution, where Catalent matches 50% of the first 6% of the employee's contributions. This plan is designed to help employees save for retirement with the added benefit of tax deferral on contributions and earnings​
Catalent has been undergoing significant restructuring since 2023, including multiple rounds of layoffs affecting various facilities. In late 2023, the company laid off approximately 300 employees as part of a cost-cutting initiative aimed at consolidating its facilities. This was followed by further layoffs in early 2024, including the reduction of 130 staff members at its Bloomington, Indiana site, which is being sold to Novo Nordisk as part of a broader $16.5 billion acquisition deal expected to close by the end of 2024. The restructuring is driven by reduced demand for COVID-19-related services and a need to increase efficiency and reduce costs across its operations. Importance: Addressing this news is crucial due to the current economic environment, where companies are navigating the aftermath of the pandemic, fluctuating demand, and economic pressures. These changes also reflect broader trends in the biopharma industry, where consolidation and cost-cutting measures are common as companies adjust to new market realities​
Stock Options: Catalent offers stock options to its employees as part of its long-term incentive plan. These options are designed to align the interests of employees with those of shareholders. Employees receive the right to purchase company stock at a predetermined price, known as the exercise price, after a specified vesting period. Restricted Stock Units (RSUs): Catalent also provides RSUs to its employees, which represent a promise to deliver shares of the company's stock in the future. RSUs typically vest over a period of time, encouraging employees to remain with the company. Once vested, the RSUs are converted into shares, which the employee can then sell or hold.
Catalent offers a comprehensive suite of health benefits to its employees, designed to meet diverse needs and foster a healthy lifestyle. Their health insurance plans cover a wide range of medical services, emphasizing both personal and financial wellness. Employees have access to wellness programs, which aim to manage healthcare costs and encourage a healthy lifestyle. These programs include health insurance, wellness incentives, and various support resources to balance work and personal life, such as generous paid time off and flexible work arrangements. In 2022, 2023, and 2024, Catalent continued to enhance its benefits offerings, aligning them with industry standards and employee needs. Recent updates include tuition reimbursement, global scholarship programs for employees' children, and comprehensive retirement plans. The company has also been recognized for its commitment to diversity and inclusion, receiving accolades as a “Best Place to Work for People with Disabilities” for consecutive years. Specific healthcare-related terms and acronyms frequently used by Catalent include "OptiDose® Design Solution," "RP Scherer Softgel Technology," and "OneXpress™ Solution," which refer to their proprietary technologies and approaches in pharmaceutical development and manufacturing. Recent employee healthcare news highlights Catalent's ongoing efforts to support employee well-being. For instance, their 2023 Corporate Responsibility Report details initiatives in employee health and wellness, such as investments in diverse and inclusive workplace practices and contributions to STEM education
New call-to-action

Additional Articles

Check Out Articles for Catalent employees

Loading...

For more information you can reach the plan administrator for Catalent at 14 Schoolhouse Road Somerset, NJ 8873; or by calling them at +1 908-809-1300.

https://www.thelayoff.com/catalent https://www.fiercepharma.com/pharma/catalent-unveils-recent-300-person-layoff-round-it-awaits-165b-novo-buyout https://bloomingtonian.com/2023/05/31/catalent-to-cut-another-150-positions-and-reorganize-in-bloomington-indiana/ https://indianapublicmedia.org/news/catalent-cutting-130-positions-at-bloomington-facility-this-week.php https://investor.catalent.com/financial-news/news-details/2024/Catalent-Inc.-Reports-Third-Quarter-Fiscal-2024-Results/default.aspx https://careers.catalent.com/us/en/benefits https://www.cashbalancedesign.com/resources/contribution-limits/ https://www.emparion.com/cash-balance-pension-plan-faq/ https://www.kiplinger.com/retirement/cash-balance-pension-plan-options https://www.futureplan.com/resources/news-articles/defined-benefit-cash-balance-plan-key-priorities/ https://investor.catalent.com/financial-news/news-details/2023/Catalent-Inc.-Reports-Preliminary-First-Quarter-Fiscal-2024-Results-and-Reaffirms-Full-Year-Fiscal-2024-Guidance/default.aspx https://careers.catalent.com/us/en/benefits https://www.fiercepharma.com/pharma/catalent-unveils-recent-300-person-layoff-round-it-awaits-165b-novo-buyout https://investor.catalent.com/ https://investor.catalent.com/financial-news/news-details/2023/Catalent-Inc.-Reports-Preliminary-Fourth-Quarter-and-Fiscal-2023-Results/default.aspx https://www.catalent.com/catalent-news/catalent-publishes-fourth-annual-corporate-responsibility-report/ https://annualreport.stocklight.com/nyse/ctlt/231007947.pdf https://creativeplanning.com/insights/financial-planning/how-to-use-the-net-unrealized-appreciation-nua-strategy-in-your-401k/ https://carlsoncap.com/articles/nua-net-unrealized-appreciation/ https://www.fidelity.com/learning-center/personal-finance/retirement/company-stock https://turbotax.intuit.com/tax-tips/retirement/net-unrealized-appreciation-nua-tax-treatment-amp-strategies/c71vBJZ2B https://investor.catalent.com/financial-news/news-details/2024/Novo-Holdings-to-Acquire-Catalent/default.aspx https://www.catalent.com/catalent-news/novo-holdings-to-acquire-catalent/ https://www.dcatvci.org/features/manufacturing-fallout-of-novos-16-5-billion-acquisition-of-catalent/ https://www.fiercepharma.com/pharma/catalent-unveils-recent-300-person-layoff-round-it-awaits-165b-novo-buyout https://www.thelayoff.com/t/1kgvERTs https://contracts.justia.com/ https://www.sec.gov/

*Please see disclaimer for more information

Relevant Articles

Check Out Articles for Catalent employees